Nomura Holdings Inc Repligen Corp Call Options Transaction History

Nomura Holdings Inc

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Nov 15, 2022	BUY	$160.42 - $256.21 $2.58 Million - $4.12 Million	16,100 New	16,100 $3.02 Million
Q4 2021 Feb 14, 2022	SELL	$247.59 - $304.47 $6.66 Million - $8.19 Million	-26,900 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$194.77 - $324.21 $8.94 Million - $14.9 Million	-45,900 Reduced 63.05%	26,900 $7.57 Million
Q2 2021 Aug 16, 2021	BUY	$165.87 - $220.95 $12.1 Million - $16.1 Million	72,800 New	72,800 $14.6 Million

487

54.4M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $6.92B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

Stay updated on Nomura Holdings Inc with notifications on news.